research use only

Insulin (human) Polypeptide

Cat.No.S6955

Insulin (human) (Insulin regular) is a polypeptide hormone that regulates the level of glucose. Insulin is commonly used to treat hyperglycemia in patients with diabetes. Potency: 29 units/mg.
Jump to

Quality Control

Batch: Purity: 99.99%
99.99

Solubility

In vitro
Batch:

0.01M HCl : 13 mg/mL

Water : Insoluble

Ethanol : Insoluble

Molarity Calculator

Mass Concentration Volume Molecular Weight
Dilution Calculator Molecular Weight Calculator

In vivo
Batch:

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg
g
μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO
%
% Tween 80
% ddH2O
% DMSO
+
%

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Chemical Information, Storage & Stability

Molecular Weight 5807.57 Formula

C257H383N65O77S6

Storage (From the date of receipt) 3 years -20°C powder
CAS No. 11061-68-0 -- Storage of Stock Solutions

Read more about storage stability stock solution CAS number

Mechanism of Action

In vitro

Insulin (human), an inducer of AKT phosphorylation, reduces the levels of LC3-II, VP1 by the AKT-AMPKMAPK-MTOR pathway in SVV-infected cells.

References

Clinical Trial Information

(data from https://clinicaltrials.gov, updated on 2026-01-06)

NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT07321028 ENROLLING_BY_INVITATION
Cellular Injury and Post-Cryogenic Recovery; Cryogenic Cellular Stress; Cold-Induced Cellular Injury; Thermal Injury Response; Post-Thaw Viability Impairment; Osmotic Stress Injury; Biomechanical Injury Modeling (In-Vitro); Blunt Force Injuries to the Extremities (Cellular Injury Model); Tissue Damage and Recovery Pathways; Hypothermic Tissue Stress; Cellular Regeneration and Repair
Truway Health, Inc.
2025-12-10 EARLY_PHASE1
NCT04062890 WITHDRAWN
Hyperinsulinism; Insulin Resistance; Insulin Sensitivity; Glucose Intolerance; Hypertension
University of Arizona
2030-04-15 PHASE2
NCT00117936 NOT_YET_RECRUITING
Coronary Disease; Coronary Heart Disease; Myocardial Ischemia; Coronary Arteriosclerosis
Venturis Therapeutics, Inc.
2027-09-01 PHASE2
NCT07593859 RECRUITING
Healthy Adult Participants
Northeastern University
2026-02-01
NCT07403604 RECRUITING
Hyperinsulinemia; Insulin Resistance; Non-Alcoholic Fatty Liver Disease; Prediabetic State; Obesity
Columbia University
2026-07-01 PHASE1
NCT07659028 NOT_YET_RECRUITING
Prediabetes; Obesity & Overweight; Inflamation; Oxidative Stress
National and Kapodistrian University of Athens
2026-07-01

Read more about Clinical Trials

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

Signaling Pathway Map